Caduceus Capital Partners has finalized its investment in ScriptDrop, a company that makes prescription delivery easy and accessible by connecting patients, pharmacies and couriers through its technology platform for a seamless experience.
When patients are unable to access their prescriptions, their health suffers. Studies show that medication non-adherence results in $100 to 289 billion in avoidable costs and nearly 125,000 deaths every year. According to a report published by the World Health Organization, improving drug adherence is the most significant way to improve human health globally. In developed countries, adherence to long-term therapy for chronic illnesses averages only 50%, causing a vast amount of avoidable suffering and financial burden.
Recommended AI News: Contentstack Now Runs on Microsoft Azure, Becoming the Only Multi-Cloud SaaS Content Management System on the Market
ScriptDrop offers a streamlined prescription delivery solution that puts medications in the hands of the patients who need them, when they need them. The company’s technology allows pharmacies to electronically request delivery on behalf of their patients. ScriptDrop then engages a nationwide courier network to take prescriptions from the pharmacy counter to the patient’s doorstep.
The company currently works with some of the country’s top grocery chains, pharmacy chains and health systems, including Albertsons, Publix, Jewel-Osco, Safeway and Vons. Notably, ScriptDrop announced a partnership with Uber last spring.
The company has scaled rapidly over the past two years, delivering five million prescriptions nationwide.
Recommended AI News: Marketplaces Face Growing Competition as 4 in 5 Shoppers Report ‘Improved Ease’ of Shopping Elsewhere
“The key to our success is bringing value to both the patient and the healthcare professional. Our process saves pharmacy techs up to 13 clicks, simplifying their work while offering a service that patients enjoy,” said Amanda Epp, CEO of ScriptDrop.
Founded in 2020, Caduceus Capital Partners invests in early-stage digital health companies that can make a significant impact on healthcare by expanding access, improving patient outcomes, reducing costs and enhancing the daily working lives of care providers.
“There are many reasons why medication adherence rates are so low – pharmacy deserts, lack of transportation, language barriers and sheer inconvenience. ScriptDrop removes these obstacles and creates a better experience,” said Dave Vreeland, senior managing partner, Caduceus Capital Partners. “We have known the ScriptDrop team for a long time and are excited to partner with them as they revolutionize prescription delivery nationwide with their proven technology.”
Recommended AI News: Rwanda’s Largest Bank Completes Core Modernization with Temenos
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.